We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

1 hedge funds and large institutions have $1K invested in POINT Biopharma Global Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

18,472% more call options, than puts

Call options by funds: $8.54M | Put options by funds: $46K

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 124

99% less funds holding

Funds holding: 125 → 1 (-124)

100% less capital invested

Capital invested by funds: $411M → $1K (-$411M)

Holders
1
Holders Change
-124
Holders Change %
-99.2%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
124
Calls
$8.54M
Puts
$46K
Net Calls
+$8.5M
Net Calls Change
+$9.58M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$1.65K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$70.5M
2
BlackRock
BlackRock
New York
-$44.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$31.1M
4
State Street
State Street
Massachusetts
-$23.5M
5
GPP
Great Point Partners
Connecticut
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
– -$665K -99,775 Closed
Fisher Asset Management
52
Fisher Asset Management
Washington
– -$662K -99,189 Closed
Two Sigma Investments
53
Two Sigma Investments
New York
– -$627K -94,042 Closed
SCM
54
Silverarc Capital Management
Massachusetts
– -$625K -93,700 Closed
UBS Group
55
UBS Group
Switzerland
– -$585K -87,639 Closed
CS
56
Credit Suisse
Switzerland
– -$565K -84,763 Closed
SO
57
STRS Ohio
Ohio
– -$554K -83,100 Closed
AA
58
ALPS Advisors
Colorado
– -$521K -78,042 Closed
Allspring Global Investments
59
Allspring Global Investments
North Carolina
– -$518K -77,736 Closed
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
– -$507K -75,995 Closed
WP
61
Woodline Partners
California
– -$492K -73,796 Closed
CIBC World Market
62
CIBC World Market
Ontario, Canada
– -$471K -70,645 Closed
Wells Fargo
63
Wells Fargo
California
– -$466K -69,934 Closed
HS
64
HighVista Strategies
Massachusetts
– -$465K -69,744 Closed
AA
65
AlphaCentric Advisors
Puerto Rico
– -$450K -67,400 Closed
Prudential Financial
66
Prudential Financial
New Jersey
– -$439K -65,840 Closed
Mirae Asset Global Investments
67
Mirae Asset Global Investments
South Korea
– -$431K -64,680 Closed
Voloridge Investment Management
68
Voloridge Investment Management
Florida
– -$415K -62,156 Closed
Legal & General Group
69
Legal & General Group
United Kingdom
– -$381K -57,054 Closed
State of Wisconsin Investment Board
70
State of Wisconsin Investment Board
Wisconsin
– -$364K -54,575 Closed
SC
71
Scotia Capital
Ontario, Canada
– -$334K -50,000 Closed
UBS AM
72
UBS AM
Illinois
– -$329K -49,289 Closed
MIM
73
MetLife Investment Management
New Jersey
– -$309K -46,389 Closed
Deutsche Bank
74
Deutsche Bank
Germany
– -$307K -45,988 Closed
AIG
75
American International Group
New York
– -$301K -45,158 Closed
1 2
3
4 5

PNT Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q4 2023, worth a combined $1K — down 100% from $411M a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of PNT and 1 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $1.65K. The largest seller was BVF Inc, exiting entirely with an estimated $70.5M sold.

  • 1 institutional investor held POINT Biopharma Global Inc. Common Stock (PNT) as of Q4 2023, down from 125 in Q3 2023.
  • Funds reported $1K of POINT Biopharma Global Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 1 fund opened new POINT Biopharma Global Inc. Common Stock positions in Q4 2023 and 124 closed out, a net change of -123 holders.
  • The largest POINT Biopharma Global Inc. Common Stock buyer in Q4 2023 was Blue Trust Inc, an estimated $1.65K added.
  • The largest POINT Biopharma Global Inc. Common Stock seller in Q4 2023 was BVF Inc, an estimated $70.5M sold.

Based on aggregated 13F filings for Q4 2023.